Bristol-Myers Squibb Company ( BMY) - Stock Earnings
BMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
BMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.1 billion USD | 12.5 billion USD |
| 2026Q1 | 2.7 billion USD | 11.5 billion USD |
| 2026Q2 | 3.3 billion USD | 13.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 8.0 billion USD | 45.0 billion USD |
| 2024 | -8.9 billion USD | 48.3 billion USD |
| 2025 | 7.1 billion USD | 48.2 billion USD |
| 2026 Est. | — | — |
BMY
List: Contenders
Price: $59.64
Dividend Yield: 4.12%
Forward Dividend Yield: 4.23%
Payout Ratio: -73.85%
Dividend Per Share: 2.52 USD
Earnings Per Share: 4.54 USD
P/E Ratio: 14.02
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 10.2 million
Ebitda: 946.0 millionMarket Capitalization: 124.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 4.72%
DGR5: 6.65%
DGR10: 5.34%
DGR20: 4.10%